XML 45 R34.htm IDEA: XBRL DOCUMENT v3.24.2.u1
REVENUE AND DEFERRED REVENUE (Tables)
6 Months Ended
Jun. 30, 2024
Schedule of percentages of deferred revenue by year

As of June 30, 2024, the Company expects to recognize approximately the following percentages of deferred revenue by year:

    

Revenue

 

Year:

Recognition

 

Remainder of 2024

62

%

2025

 

35

%

2026

 

2

%

2027

 

1

%

Total

 

100

%

Schedule of revenue generated in geographic regions for years indicated

Revenues by Geography

 

Three Months Ended June 30, 

 

2024

2023

 

% of

% of

 

Amount

Revenues

Amount

Revenues

 

(in thousands, except percentages)

U.S.

    

$

16,130

    

98

%  

$

17,289

    

98

%

International

 

320

 

2

%  

 

321

 

2

%

Total revenues

$

16,450

 

100

%  

$

17,610

 

100

%

Revenues by Geography

 

Six Months Ended June 30, 

 

2024

2023

 

% of

% of

 

Amount

Revenues

Amount

Revenues

 

(in thousands, except percentages)

U.S.

    

$

32,923

    

97

%  

$

32,253

    

97

%

International

 

944

 

3

%  

 

897

 

3

%

Total revenues

$

33,867

 

100

%  

$

33,150

 

100

%

U.S.  
Schedule of revenue generated in product category for years indicated

U.S. Revenues by Product Category

 

Three Months Ended June 30, 

 

2024

2023

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

4,000

25

%  

$

4,489

26

%

Treatment sessions

 

11,660

 

72

%

 

12,314

 

71

%

Other

 

470

 

3

%

 

486

 

3

%

Total U.S. revenues

$

16,130

 

100

%

$

17,289

 

100

%

U.S. Revenues by Product Category

 

Six Months Ended June 30, 

 

2024

2023

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

7,310

22

%  

$

8,339

26

%

Treatment sessions

 

24,648

 

75

%

 

22,957

 

71

%

Other

 

965

 

3

%

 

957

 

3

%

Total U.S. revenues

$

32,923

 

100

%

$

32,253

 

100

%

International  
Schedule of revenue generated in product category for years indicated

International Revenues by Product Category

 

Three Months Ended June 30, 

 

2024

2023

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

 

%  

$

56

 

18

%

Treatment sessions

 

139

 

43

%  

 

126

 

39

%

Other

 

181

 

57

%  

 

139

 

43

%

Total international revenues

$

320

 

100

%  

$

321

 

100

%

International Revenues by Product Category

 

Six Months Ended June 30, 

 

2024

2023

 

% of

% of

 

    

Amount

    

Revenues

    

Amount

    

Revenues

 

 

(in thousands, except percentages)

NeuroStar Advanced Therapy System

$

259

 

27

%  

$

314

 

35

%

Treatment sessions

 

309

 

33

%  

 

310

 

35

%

Other

 

376

 

40

%  

 

273

 

30

%

Total International revenues

$

944

 

100

%  

$

897

 

100

%